Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model.

MLA

Kitazawa, Masashi, et al. “Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model.” Journal of Immunology (Baltimore, Md. : 1950), vol. 187, no. 12, Dec. 2011, pp. 6539–49. EBSCOhost, https://doi.org/10.4049/jimmunol.1100620.

APA

Kitazawa, M., Cheng, D., Tsukamoto, M. R., Koike, M. A., Wes, P. D., Vasilevko, V., Cribbs, D. H., & LaFerla, F. M. (2011). Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer’s disease model. Journal of Immunology (Baltimore, Md. : 1950), 187(12), 6539–6549. https://doi.org/10.4049/jimmunol.1100620

Chicago

Kitazawa, Masashi, David Cheng, Michelle R Tsukamoto, Maya A Koike, Paul D Wes, Vitaly Vasilevko, David H Cribbs, and Frank M LaFerla. 2011. “Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model.” Journal of Immunology (Baltimore, Md. : 1950) 187 (12): 6539–49. doi:10.4049/jimmunol.1100620.